Search Results for: asthma
Antimicrobial guidance and resources
The BTS recommendations on the prescribing of long-term azithromycin in adults with a diagnosis of asthma, COPD or bronchiectasis are summarised in the table in appendix 1. Asthma & COPD these patients should ideally have their initial 3 to 6 month review performed by their respiratory consultant.
GM Alllergy Centre Acarizax and Itulazax primary care guidance – v1.0 for web
SLIT may modify the natural history of allergic disease, with evidence suggesting a potential reduction in the risk of progression from allergic rhinitis to asthma and possibly in the development of new allergen sensitisations. – Stable asthma. – Mild worsening of rhinitis/asthma.
Minutes March 2022 GMMMG fnl
Action: AM to seek consider comments made by community pharmacy colleagues and return item to next available meeting 5.0 GM Asthma Pathway GMMMG considered the recently revised Greater Manchester Asthma Management Plan from 2018, reflecting revisions to national NICE guidance NG80 (published 2017, updated 2021).
GMMMG-PBR-Ex-Drugs-2020-21-Oct-2020
Row 196 dupilumab amended to NHSE-commissioned in asthma as per V11,,,, Row 360 lebrikuzumab amended to NHSE-commissioned in asthma as per V11,,,, , 107,Benralizumab ,N,Allergen Immunotherapy,3.4,Group,Asthma – uncontrolled on high-dose inhaled corticosteroid + LABA – in adults and adolescents,,,,
Clinical Guidance and Pathways
SLIT may modify the natural history of allergic disease, with evidence suggesting a potential reduction in the risk of progression from allergic rhinitis to asthma and possibly in the development of new allergen sensitisations. – Stable asthma. – Mild worsening of rhinitis/asthma.
GMMMG recommendations to CEGC Jan 23 meeting
…below) independent purchase of nebuliser devices outside of medical advice for use at home to deliver rescue therapy for the acute in chapter 3.1.1 GMMMG formulary and asthma guidance apply to adults only.
Subgroup Decision Table May 2022
GMMMG asthma Green Following the update to the GM asthma Cost impact difficult to estimate None Approved and COPD formulary sections pathway, the corresponding formulary section as communicated to Docs and has been updated to reflect the changes.
GMMMG minutes Nov 25 FINAL
The challenge is therefore to improve respiratory disease ĐĂƌĞĂŶĚƚŽůŽǁĞƌƚŚĞƐLJƐƚĞŵ͛ƐĐĂƌďŽŶĨŽŽƚƉƌŝŶƚĂƚƚŚĞƐĂŵĞƚŝŵĞ͘ŚŝƐŝƐďĞŝŶg achieved through the COPD and asthma guidelines, ensuring the right inhaler is prescribed at the right time and providing personalised asthma plans.
GMMMG decision summary Sept 2024 for publication approved 230924
This guideline is intended to provide detailed guidance on asthma pharmacotherapy and therefore detailed diagnostic detail is outwith its scope. DuoResp Spiromax 160/4.5, WockAir 160/4.5 As this update represents a significant change in the way asthma is treated, training and support materials will be produced.
FSG-minutes-August-2015
The group reviewed a draft COPD pathway which has recently be approved for use across GM by NTS and discussed the production of an asthma pathway. HB shared an asthma pathway currently in use across the Manchester CCGs.